Search results
ANGLE inks AstraZeneca deal to develop ground-breaking cancer assay
Proactive Investors· 7 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with ...
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 6 days agoAstraZeneca revealed soaring sales over the latest quarter as it was boosted by its cancer drugs....
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 6 days agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
AstraZeneca Earnings, Sales Rise, Beat Forecasts
The Wall Street Journal· 6 days agoHEALTH AstraZeneca posted increased first-quarter core earnings per share and sales that beat forecasts. The Anglo-Swedish pharmaceutical giant said...
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via AOL· 6 days agoAstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by...
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
BioPharma Dive via Yahoo Finance· 6 days agoAstraZeneca’s revenue and profits grew at a rapid clip over the first three months of the year,...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AOL· 5 days agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company reported $12.7 billion in revenue, beating consensus estimates of $11.8 billion ...
AstraZeneca profit up on strong sales of cancer drugs
Medical Xpress· 6 days agoBritish pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg· 6 days agoAstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu.
AstraZeneca beats revenue, profit estimates on resilient demand
Reuters· 6 days agoAstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by...